Revenue ₹689 Cr (+6.11% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Alivus Life Sciences LimitedAlivus Life Sciences delivered a strong Q4 FY26 with revenue of 689 crore (+6.1% YoY) and EBITDA margin of 34.4% (+23...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
2026-04-??
Revenue ₹689 Cr (+6.11% YoY)
Alivus Life Sciences delivered a strong Q4 FY26 with revenue of 689 crore (+6.1% YoY) and EBITDA margin of 34.4% (+230 bps YoY), driven by favorable product mix, cost...
bullish
high
Scorecard starts after historical backfill
Read full analysis →
Q3 FY26
15 Jan 2026
Revenue ₹673 Cr (+4.8% YoY)
Alivus Life Sciences reported its highest-ever quarterly revenue of ₹673 crore, up 4.8% YoY, driven by a strong CDMO recovery (85.3% YoY growth) and robust non-GPL bus...
bullish
high
Scorecard starts after historical backfill
Read full analysis →
Q2 FY26
30 Oct 2025
Revenue ₹588 Cr (+16% YoY)
Alivus Life Sciences reported a strong Q2 FY26 with revenue of ₹588 crore (up 16% YoY) and EBITDA margin of 33% (up 480 bps YoY), driven by a 39.7% growth in non-GPL A...
bullish
high
Scorecard starts after historical backfill
Read full analysis →